Some 82% of working Americans over 50 say it is at least somewhat likely they will work for pay in retirement, according to a poll released Monday by the Associated Press-NORC Center for Public Affairs Research.
The survey found 47% of working survey respondents now expect to retire later than they previously thought and, on average, plan to call it quits at about 66, or nearly three years later than their estimate when they were 40. Men, racial minorities, parents of minor children, those earning less than $50,000 a year and those without health insurance were more likely to put off their plans.
Best Quality Stocks To Buy For 2015: IPC The Hospitalist Company Inc.(IPCM)
IPC The Hospitalist Company, Inc., through its subsidiaries, provides hospitalist services in the United States. It engages in providing, managing, and coordinating the care of hospitalized patients and serves as the inpatient partner of primary care physicians and specialists. As of December 31, 2011, the company with its 1,201 affiliated hospitalists, including physicians, nurse practitioners, and physician assistants that are organized into medical group practices, provided hospitalist solutions at approximately 365 hospitals, and 550 other inpatient and post-acute care facilities primarily in 25 states. It also offers administrative and professional services, including information management system, transition management, regional management, recruiting, training, financial reporting, billing and collection, risk management, and compliance services to affiliated hospitalists. The company serves patients, primary care physicians, specialists, acute care hospitals, alter native sites of inpatient care, and health plans. IPC The Hospitalist Company, Inc., formerly known as InPatient Consultants Management, Inc., was founded in 1995 and is headquartered in North Hollywood, California.
Advisors' Opinion:- [By Garrett Cook]
Shares of IPC The Hospitalist Company (NASDAQ: IPCM) were down 19.15 percent to $38.03 after the company reported downbeat Q3 results and lowered its FY14 forecast.
- [By Jake L'Ecuyer]
Equities Trading DOWN
Shares of IPC The Hospitalist Company (NASDAQ: IPCM) were down 2.60 percent to $56.98 after Credit Suisse downgraded the stock from Outperform to Neutral.
Top 10 Healthcare Equipment Companies To Own In Right Now: KKR(KKR)
Kohlberg Kravis Roberts & Co. is a private equity and venture capital firm specializing in acquisitions, leveraged buyouts, management buyouts, and mezzanine investments in large cap companies. The firm will consider investments in all industries globally, with a focus on financial services, infrastructure, and renewable energy. It seeks a board seat in its portfolio companies. The firm holds a controlling interest in its portfolio companies after they go public. It typically holds its investment for a period of five years and more and exits through initial public offerings, secondary offerings, and sales to strategic buyers. Kohlberg Kravis Roberts & Co. was founded in 1976 and is based at New York, New York with additional offices across United States, Europe, Australia, and Asia.
Advisors' Opinion:- [By Reuters]
Itsuo Inouye/APA Panasonic 150-inch high-definition plasma TV on display at a 2008 expo in Tokyo. TOKYO -- Panasonic will pull out of the plasma television panel business by the end of the financial year to March 2014, sources familiar with the situation told Reuters, marking a key milestone in the long-term decline of Japan's TV industry. Panasonic had been widely expected to back out of the unprofitable business, but the exit comes sooner than predicted and underlines President Kazuhiro Tsuga's determination to weed out weak operations as he focuses on higher-margin products to end years of losses at the consumer electronics conglomerate. Panasonic's TV division has been a major contributor to the electronics company's combined $15 billion (9 billion pounds) net loss in its two latest financial years. Its TV business posted an operating loss of 88.5 billion yen ($913 million) in the last financial year. With the closure of its sole plasma panel factory in western Japan, Panasonic will book an impairment loss of more than 40 billion yen on the last remaining factory building in operation, the sources added. The company set aside 120 billion yen to cover restructuring costs at the start of the current financial year. The move also signals the demise in Japan of a technology in which TV makers once invested heavily but has now been overtaken by advances in the liquid crystal display business. Plasma display TVs accounted for less than 6 percent of global shipments in 2012, compared with 87 percent for LCD TVs, according to research firm DisplaySearch. Squeezed by the strong yen in recent years, Japan's TV makers have also lost their innovative edge against nimbler rivals such as South Korea's Samsung Electronics, with deep resources to spend on research and development. Sony (SNE), Panasonic and Sharp combined had a less than 20 percent share of the worldwide flat panel TV market by revenue. Samsung had a 27.7 percent share, and LG Electronics had 15 pe
- [By Charles Sizemore]
The normally sleepy world of senior housing REITs got a shakeup on Wednesday with the announcement that Health Care REIT (HCN) and Revera Inc., a leading provider of senior living facilities in Canada, had partnered to purchase and recapitalize Sunrise Senior Living, LLC from affiliates of private equity firmKohlberg Kravis Roberts & Co (KKR).
Top 10 Healthcare Equipment Companies To Own In Right Now: Biomerieux SA (BIM)
Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, such as bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, bioMerieux Benelux SA/NV, among others. In January 2014, it acquired 100% stake in BioFire Diagnostics Inc. Advisors' Opinion:- [By Jonathan Morgan]
BioMerieux (BIM) jumped 3.8 percent to 76.53 euros, the largest gain in eight months. The French maker of tests for HIV and hepatitis reported sales for the first half of 754 million euros and confirmed its revenue-growth forecast.
Top 10 Healthcare Equipment Companies To Own In Right Now: Cytomedix Inc (CMXI)
Cytomedix, Inc. (Cytomedix), incorporated in April 29, 1998, is a regenerative therapies company marketing and developing products within the United States and internationally .The Company commercializes cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing. The Company is a commercial operation, and a robust clinical pipeline representing a logical extension of its commercial technologies in the evolving field of regenerative medicine. Cytomedix primarily operates in the United States. Its commercial offerings are centered on its point of care platform technologies for the safe and efficient separation of blood and bone marrow to produce platelet based therapies or cell concentrates.
The Company markets and selsl two distinct platelet rich plasma (PRP) technologies, the AutoloGel System for wound care and the Angel concentrated Platelet Rich Plasma (cPRP) Sytem in orthopedic and cardiovascular markets. Its clinical pipeline includes the ALDH, which are cell-based therapies (Bright Cells). In February 2012, the Company acquired Aldagen, Inc.
The AutoloGel System
The AutoloGel System is a point of care device for the production of a platelet based bioactive therapy derived from a small sample of the patient�� own blood. Using the patient�� own platelets as a therapeutic agent, AutoloGel harnesses the body�� natural healing processes to deliver growth factors, chemokines and cytokines known to promote angiogenesis and to regulate cell growth and the formation of new tissue.
Angel Product Line
The Angel concentrated Platelet Rich Plasma (cPRP) System is a multi-functional cell separation device which produces concentrated platelet rich plasma for use in the operating room and clinic and is used in a range of orthopedic and cardiovascular indications. Similar to the AutoloGel System, the Angel System is a point of care device for the production of a concentrated, aseptic platelet! -based bioactive therapy derived from a small sample of the patient�� own blood. The resulting cPRP is applied at the site of injury to promote healing. The Angel product line also includes ancillary products such as phlebotomy and applicator supplies and activAT. activAT is designed to produce autologous thrombin serum from platelet poor plasma and is sold exclusively in Europe and Canada, where it provides a safe alternative to bovine-derived products.
ALDHbr Cell Technology and Development Pipeline
The ALDHbr (Bright Cell) technology is an approach to cell-based regenerative medicine and a logical extension of its commercial technologies in the evolving regenerative medicine market, with potential clinical indications in markets with unmet medical needs such as peripheral arterial disease and ischemic stroke. The Bright Cell technology is in that it utilizes an intracellular enzyme marker to facilitate fractionation of essential regenerative cells from a patient�� bone marrow. The bone marrow fractionation process identifies and isolates active stem and progenitor cells expressing high levels of the enzyme aldehyde dehydrogenase, or ALDH, which is a key enzyme involved in the regulation of gene activities associated with cell proliferation and differentiation.
The Company�� lead product candidate, ALD-401, is an autologous preparation of Bright Cells for the post-acute treatment of ischemic stroke. ALD-401 is being evaluated in the RECOVER-Stroke clinical study, an ongoing 100-patient, double-blind, placebo-controlled Phase 2 study in patients with unilateral, cerebral ischemic stroke with an NIH stroke scale score of less than 22. An additional product candidate, ALD-301, is in clinical development for peripheral arterial disease (PAD), a condition causing reduced flow of blood and oxygen to muscles in the leg. It has completed a Phase 1/2 study of autologous ALD-301 in critical limb ischemia (CLI), a late stage condition caused by PAD. The Phase 2 PACE! (Patient! s with Intermittent Claudication Injected with ALDH Bright Cells) study is an 80 patient, double-blind, placebo-controlled clinical trial intended to demonstrate the safety and efficacy of ALD-301 (Bright Cells) in patients diagnosed with IC.
The Company competes with Harvest Technologies (a subsidiary of Terumo), Biomet, Arteriocyte, and Arthrex.
Advisors' Opinion:- [By Bryan Murphy]
When traders think of post-surgical wound management stocks, they may first think of names like Cytomedix, Inc. (OTCBB:CMXI) or Alliqua Inc. (OTCMKTS:ALQA). And well they should. Both companies have something of a history in the arena. ALQA is the purveyor of SilverSeal and Hydress antibiotic bandages, while CMXI is the developer of the AutoloGel system, which induces an affected patient's on body to do what it's supposed to do if there's a wound that won't heal. Cytomedix also makes the Angel platelet-rich plasma (PRP) delivery system. There's a relatively new name to add to the list of game-changing stocks in wound-management industry, however.... Arch Therapeutics Inc. (OTCBB:ARTH). The company is developing - well, has developed - a product called AC5 that nips post-surgical bleeding in the bud, largely negating the need for other post-surgical bleeding-control measures.
- [By James E. Brumley]
To give credit where it's due, Cytomedix, Inc. (OTCBB:CMXI) and Baxter International Inc. (NYSE:BAX) have both helped shape the landscape of the hemostasis (bleeding control) market with their products, AutoloGel and TISSELL, respectively. Arch Therapeutics Inc. (OTCBB:ARTH) has proverbially taken their concepts "up a notch", however, and its direct solution to a problem that CMXI and BAX can't quite solve may make ARTH the hottest trading candidate in the hemostasis space.
Top 10 Healthcare Equipment Companies To Own In Right Now: Manitex International Inc.(MNTX)
Manitex International, Inc. provides engineered lifting solutions. The company operates through two segments, Lifting Equipment and Equipment Distribution. The Lifting Equipment segment designs, manufactures, and distributes boom trucks and crane products that are primarily used for industrial projects and energy exploration, as well as for infrastructure development, including, roads, bridges, and commercial construction; and specialized rough terrain cranes and material handling products for the construction, municipality, and railroad industries. This segment also provides rough terrain forklifts for use in commercial and military applications; special mission oriented vehicles; and other specialized carriers, heavy material handling transporters, and steel mill equipment, as well as offers specialized custom trailers and hauling systems used for transporting heavy equipment. The Equipment Distribution segment distributes rough terrain and truck cranes, material handler s, boom trucks, and sky cranes for infrastructure development and commercial construction; supplies repair parts for various medium to heavy duty construction equipment; markets used lifting and construction equipment; and offers repair services. This segment sells its products to end users, including the rental market. Manitex International sells its products primarily in the United States, Canada, Algeria, the United Arab Emirates, Brazil, Italy, Korea, Mexico, China, Russia, Spain, Turkey, Puerto Rico, the Netherlands, Indonesia, and Chile. The company was formerly known as Veri-Tek International, Corp. and changed its name to Manitex International, Inc. in May 2008. Manitex International was founded in 1993 and is based in Bridgeview, Illinois.
Advisors' Opinion:- [By Zacks Investment Research]
1. Manitex International, Inc. (MNTX)
Manitex manufactures lifting solutions including cranes, reach stackers and container handling equipment, rough terrain forklifts, and indoor electric forklifts. Headquartered in Illinois, it supplies crane parts to customers throughout the world.
Top 10 Healthcare Equipment Companies To Own In Right Now: RMP Energy Inc (OEXFF.PK)
RMP Energy Inc. (RMP) is a crude oil and natural gas company. The Company is engaged in the exploration for, development and production of natural gas, crude oil and natural gas liquids (NGLs) reserves within the provinces of Alberta and Saskatchewan, Canada. RMP conducts its operations in the Western Canadian Sedimentary Basin, primarily in the provinces of Alberta and Saskatchewan. The Company�� principal properties include Gilby, Pine Creek, Kaybob, Waskahigan, Ante Creek, Ricinus, Gordondale, Resthaven/Bilbo and Big Muddy. The Gilby property is located 110 kilometers southwest of Edmonton, Alberta. Kaybob property is located 250 kilometers northwest of Edmonton, Alberta and consisted of 31 producing and non-producing gas wells as of December 31, 2011. In November 2013, RMP Energy Inc closed the purchase of complementary Montney light oil assets located in its core areas of Ante Creek and Waskahigan in West Central Alberta. Advisors' Opinion:- [By Value Digger]
As peers, I selected Artek Exploration (ARKXF.PK), RMP Energy (OEXFF.PK), Synergy Resources (SYRG) and Magnum Hunter Resources (MHR). The first two firms trade also on the main Toronto board under the tickers RTK.TO and RMP.TO respectively. These peers comply with the following criteria:
Top 10 Healthcare Equipment Companies To Own In Right Now: Uranium Resources Inc.(URRE)
Uranium Resources, Inc. engages in the acquisition, exploration, development, and mining of uranium properties, using the in situ recovery or solution mining process. It owns developed and undeveloped uranium properties in South Texas; and undeveloped uranium properties in New Mexico. The company?s primary customers include utilities who utilize nuclear power to generate electricity. Uranium Resources, Inc. was founded in 1977 and is based in Lewisville, Texas.
Advisors' Opinion:- [By John Udovich]
Small cap nuclear fuel stock USEC Inc (NYSE: USU) is up some 300% this week���meaning its worth taking a closer look at the company along with the performance potential uranium or nuclear stock peers Uranium Resources, Inc (NASDAQ: URRE), Denison Mines Corp (NYSEMKT: DNN), Ur-Energy Inc (NYSEMKT: URG) and Uranerz Energy Corp (NYSEMKT: URZ).
- [By John Udovich]
Since the start of the week, small cap nuclear fuel stock USEC Inc (NYSE: USU) more than doubled for investors, something that has not happened for investors in uranium stocks like Uranium Resources, Inc (NASDAQ: URRE), Denison Mines Corp (NYSEMKT: DNN), Ur-Energy Inc. (NYSEMKT: URG) and Uranerz Energy Corp (NYSEMKT: URZ). To recap: USEC Inc closed at the $6 level on Friday, but then it surged to the $15 level on Monday only to open at the $10 level on Tuesday when it ultimately closed at $12.46. So what in the world is going on with USEC Inc and is it time to revisit nuclear fuel and uranium stocks?
- [By Bryan Murphy]
If you listened to my bullish calls from December 27th and/or February 24th about Uranerz Energy Corp. (NYSEMKT:URZ), Uranium Resources, Inc. (NASDAQ:URRE), and Ur-Energy Inc. (NYSEMKT:URG), then congratulations - you're now up as much as 50%, depending on when you stepped into a trade, and which stock you chose. Now get out. See, as well as URZ and URG have done and are doing (URRE not so much), it looks like the short-term rally I first spotted a little more than a couple of months ago has fully run its course, and now these names are setting up a pullback.
- [By James E. Brumley]
Well, I'll give myself an A for effort, but a C- for timing. But, I can bump that C- up to a B+ if my intuition is right as we head into the last few days of 2013 and the first few of 2014. What I'm talking about is a bullish commentary I penned back on November 26th regarding Uranerz Energy Corp. (NYSEMKT:URZ), Uranium Resources, Inc. (NASDAQ:URRE), and Ur-Energy Inc. (NYSEMKT:URG). All three stocks were perking up, and more than that, the buzz surrounding URG, URRE, and URZ was getting louder. More often than not, when the fervor and bullish action and chatter reaches the levels they had reached a month ago, an explosion is right around the corner.
No comments:
Post a Comment